Filter
1799
Filtered Results: 1799
Text search:
antigen
Featured
Recommendations
214
New Publications
411
Language
Document type
No document type
857
Guidelines
439
Studies & Reports
209
Manuals
99
Strategic & Response Plan
65
Fact sheets
64
Training Material
18
Situation Updates
18
Brochures
9
Infographics
9
Resource Platforms
5
Online Courses
4
Videos
3
Countries / Regions
India
84
Global
64
Germany
56
Brazil
54
Latin America and the Carribbean
40
Africa
35
Western and Central Europe
34
Kenya
30
Nigeria
30
South Africa
30
Congo, Democratic Republic of
27
Argentina
27
Uganda
24
Sierra Leone
22
Tanzania
22
Paraguay
22
Colombia
21
Nepal
20
Rwanda
20
East and Southern Africa
20
Philippines
19
Zambia
19
Ukraine
18
Malawi
17
Liberia
17
West and Central Africa
16
Ghana
15
Senegal
15
Mozambique
15
Ethiopia
15
Burkina Faso
14
Bangladesh
13
Russia
13
Indonesia
13
Cameroon
12
Zimbabwe
12
Chile
11
Middle East and North Africa
11
Bolivia
11
Peru
10
Namibia
10
Myanmar / Burma
10
El Salvador
9
Venezuela
9
South–East Asia Region
9
Ecuador
8
Syria
7
Eastern Europe and Central Asia
7
Madagascar
7
Lesotho
6
Benin
6
Guinea
6
Haiti
6
Eastern Europe
6
Angola
6
Asia
5
Pakistan
5
Niger
4
USA
4
Cambodia
4
Spain
4
Central African Republic
4
Mali
4
Botswana
4
Somalia
4
Albania
3
Afghanistan
3
Saudi Arabia
3
Côte d’Ivoire / Ivory Coast
3
Papua New Guinea
3
Sudan
3
Honduras
3
Libya
3
South Sudan
3
Togo
2
Iran
2
Congo-Brazzaville
2
Guinea-Bissau
2
Jordan
2
Western Pacific Region
2
North America
2
France
2
Portugal
2
Lebanon
2
Djibouti
2
Chad
2
Iraq
2
Eswatini/ Swaziland
2
Guatemala
2
North Macedonia
1
Switzerland
1
Timor Leste/ East Timor
1
Mexico
1
China
1
Kazakhstan
1
Canada
1
Burundi
1
Morocco
1
Qatar
1
Dominican Republic
1
Luxembourg
1
Uruguay
1
Belgium
1
Tunisia
1
United Kingdom
1
Southern Africa
1
Nicaragua
1
Moldova
1
Sri Lanka
1
Egypt
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
752
Clinical Guidelines
245
Pharmacy & Technologies
67
Public Health
66
Women & Child Health
40
Key Resources
28
Capacity Building
16
Toolboxes
COVID-19
359
HIV
155
TB
142
Rapid Response
124
NTDs
113
Ebola
61
Refugee
42
Pharmacy
29
Mental Health
28
Zika
25
Caregiver
23
Polio
18
Conflict
17
AMR
17
NCDs
14
Planetary Health
13
Cholera
10
Natural Hazards
9
Health Financing Toolbox
6
Specific Hazards
5
Global Health Education
5
Disability
1
Social Ethics
1
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities in West and Central Africa, where access to proper health care is lim...
The socioeconomic factors and public health inadequacies that facilitated the rapid spread of this infection continue to exist. As it is a new and emerging disease it has not received sufficient coverage yet in the medical curricula of Member States. Specific treatment is not available, and there is...
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national health budget in developing countries, yet portions o...
In 1997, the Fiftieth World Health Assembly adopted resolution WHA50.29 on the elimination of
lymphatic filariasis as a public health problem. Preliminary guidance from WHO printed in 2011 referred to “verification” as the official process by which the achievements of the Global Programme to El...
International commitment to eliminate trachoma as a public health problem worldwide is supported by resolution WHA51.11 of the World Health Assembly .1 Important progress towards this goal has been made by harnessing the mostly informal relationships that exist between partners including Member Stat...
SECOND MEETING REPORT
DECATUR, GA, USA, 26 JUNE 2016
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This document will focus mainly
on preventing, predicting and detecting outbreaks, and after detection,
investig...
Schistosomiasis is a helminthic infection and one of the neglected tropical diseases (NTDs). It is caused by blood flukes of the genus Schistosoma. It is an important public health problem, particularly in poverty-stricken areas, especially those within the tropics and subtropics. It is estimated th...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para...
During the year 2022, COVID-19 continued to be a significant challenge in Eritrea as in many other countries across the world. As COVID-19 devastated communities around the world, WHO worked with the MoH to strengthen the National and Sub-National health systems in order to meet community needs and ...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
This brochure presents a summary of the situation of health systems and services in the Americas as they progress toward the achievement of universal access to health and universal health coverage (universal health). The information provided presents an overview of the situation before the COVID-19 ...
Mycetoma is a chronic infectious disease of the subcutaneous tissue with a high morbidity. This disease has been reported from countries between 30°N and 15°S since 1840 but the exact burden of disease is not known. It is currently unknown what the incidence, prevalence and the number of reported ...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t...
Burden of T. solium: Neurocysticercosis is a disease induced by T. solium larvae penetrating human tissues, especially the nervous system. Neurocysticercosis burdens economies, societies and individuals because of the impact of epilepsy on wages, health costs and social stigmatization of sufferers. ...
The epidemiology of the disease is mediated by the interaction of the parasite (trypanosome) with the vectors (tsetse flies), as well as with the human and animal hosts within a particular environment. Related to these interactions, the disease is confined in spatially limited areas called “foci...
The objective of this concept note and the framework it outlines is the elimination of a group of CDs and the negative health effects they generate, which together create a tangible burden on affected individuals, their families and communities, and on health care systems throughout the Region. Thou...
In 2014, an estimated 40 million women of reproductive age were infected with Schistosoma haematobium, S. japonicum and/or S. mansoni. In both 2003 and 2006, the World Health Organization (WHO) recommended that all schistosome-infected pregnant and breastfeeding women be offered treatment, with praz...
